Frank J. Williams - 17 May 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Executive Chairman, Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
17 May 2021
Net transactions value
-$356,200
Form type
4
Filing time
19 May 2021, 20:15:45 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Frank J. Williams filed Form 4 for Evolent Health, Inc. (EVH) on 19 May 2021."

Quick Takeaways

  • This page summarizes Frank J. Williams's Form 4 filing for Evolent Health, Inc. (EVH).
  • 4 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 19 May 2021, 20:15.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$356,200.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $38,400 +10,000 +1.5% $3.84* 670,509 17 May 2021 Direct F1, F2
transaction EVH Class A Common Stock Sale $198,100 -10,000 -1.5% $19.81 660,509 17 May 2021 Direct F1, F2, F3
transaction EVH Class A Common Stock Sale $196,500 -10,000 -1.5% $19.65 650,509 17 May 2021 Direct F1, F2, F4
holding EVH Class A Common Stock 92,848 17 May 2021 See Footnote. F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -10,000 -1.4% $0.000000 726,560 17 May 2021 Class A Common Stock 10,000 $3.84 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2021.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $19.90, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.41 to $19.82, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Shares held of record by the Williams 2019 GRAT. Mr. Williams serves as Trustee of the Williams 2019 GRAT.
F6 The Class A Common Stock Options exercised vested on December 1, 2014.

Sponsored